Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart … – Xconomy
Xconomy |
Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart …
Xconomy A growing number of companies are using CRISPR technology to try and develop more precise treatments for a wide range of diseases, and Locus Biosciences … |
